Asciminib monotherapy in patients with chronic myeloid leukemia in chronic phase without BCR::ABL1(T315I) treated with at least 2 prior TKIs: Phase 1 final results
Asciminib单药治疗既往接受过至少2种TKI治疗的慢性期慢性粒细胞白血病(无BCR::ABL1(T315I)突变)患者:I期临床试验最终结果
期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-025-02578-7
Hochhaus, Andreas; Kim, Dong-Wook; Cortes, Jorge E; Sasaki, Koji; Mauro, Michael J; Hughes, Timothy P; Breccia, Massimo; Talpaz, Moshe; Minami, Hironobu; Goh, Yeow Tee; DeAngelo, Daniel J; Lang, Fabian; Ottmann, Oliver; Heinrich, Michael C; Gomez Garcia de Soria, Valle; le Coutre, Philipp; Sanchez-Olle, Gessami; Cao, Meng; Pognan, Nathalie; Kapoor, Shruti; Hoch, Matthias; Rea, Delphine